IP Library Granted Patent US 10,478,584
Granted Patent B2
US 10,478,584 · App. 15/420,689 · Granted Nov 19, 2019

Compensating for disruptions in breathing gas flow measurement

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,478,584
App. No.
15/420,689
Granted
Nov 19, 2019
Kind
B2
Abstract

The present disclosure generally relates to systems and methods for delivery of therapeutic gas to patients, using techniques to compensate for disruptions in breathing gas flow measurement, such as when breathing gas flow measurement is unavailable or unreliable. Such techniques include using historical breathing gas flow rate data, such as moving average flow rates, moving median flow rates and/or flow waveforms. At least some of these techniques can be used to ensure that interruption in therapeutic gas delivery is minimized or eliminated.

Claims (40)

1. A therapeutic gas delivery apparatus for use with a ventilator, the apparatus comprising:

a therapeutic gas injector module configured to be placed in fluid communication with a breathing circuit affiliated with the ventilator, the therapeutic gas injector module including a breathing gas flow inlet, a therapeutic gas flow inlet, and a combined breathing gas and therapeutic gas flow outlet for providing a combined flow of breathing gas and therapeutic gas to a patient, in need thereof;

a first flow sensor configured to sense breathing gas flow rate data; and

a controller configured to control the delivery flow rate of the therapeutic gas based on a first mode, and upon detection of a disruption of the sensed breathing gas flow rate data, configured to control delivery flow of the therapeutic gas based on the historical breathing gas flow rate data previously sensed by the first flow sensor and stored in the memory.

2. The apparatus of claim 1 , wherein the controller comprises:

a memory configured to store historical flow rate data related to the sensed breathing gas flow rate data by the first flow sensor; and

a processor configured to detect a disruption of the sensed breathing gas flow rate data from the first flow sensor, and

wherein the first flow sensor is a gas inspiratory flow sensor, and the controller is configured to use the historical breathing gas flow rate based on a historical average upon detection of a disruption in the form of a failure of an operation of a gas inspiratory flow sensor.

3. The apparatus of claim 2 , wherein the historical flow rate data includes one or more of a moving average breathing gas flow rate, a moving median breathing gas flow rate, and/or a gas flow rate waveform.

4. The apparatus of claim 2 , wherein the historical flow rate data is stored over a period in the range from 10 seconds to 5 minutes.

5. The apparatus of claim 1 , wherein the sensed breathing gas flow rate is received from the injector module and/or the ventilator.

6. The apparatus of claim 1 , wherein the therapeutic gas is inhaled Nitric Oxide.

7. The apparatus of claim 1 , wherein the sensed breathing gas flow rate data comprises first breathing gas flow rate data and second breathing gas flow rate data, and wherein the first breathing second gas flow rate data is received from the injector module and/or the second breathing gas flow rate data is received from the ventilator.

8. The apparatus of claim 7 , wherein the controller compares respective flow rate data from the first breathing gas flow rate data with the second breathing gas flow rate data.

9. The apparatus of claim 1 , wherein the controller is configured to automatically resume delivery of a flow of therapeutic gas based on the first mode, upon detection and/or input that the first flow sensor has been at least one of reconnected, replaced, and/or serviced.

10. The apparatus of claim 1 , wherein the controller is further configured to utilize at least one of data smoothing and/or low-pass filtering to remove outlying stored flow data points.

11. A method for delivery of therapeutic gas to a patient, the method comprising:

controlling via a controller therapeutic gas flow to a patient in a first mode;

receiving, via a sensor, sensed flow rate data of breathing gas flow;

storing in a memory historical flow rate data related to the received breathing gas flow rate data by the sensor;

detecting a disruption of the sensed breathing gas flow rate data from the sensor; and

controlling via the controller the therapeutic gas flow in a temporary mode instead of the first mode, based on the received breathing gas flow rate data.

12. The method of claim 11 , wherein the historical sensed flow rate data comprises one or more of a moving average breathing gas flow rate, a moving median breathing gas flow rate, and/or a gas flow rate waveform.

13. The method of claim 12 , wherein storing the historical flow data includes storing the historical flow rate data over a period in the range from 10 seconds to 5 minutes.

14. The method of claim 11 , further comprising:

returning to the first mode when a discontinuance of the disruption is detected.

15. The method of claim 14 , wherein:

receiving the received flow rate data includes receiving a first received flow rate data and a second received flow rate data from, and

detecting the disruption includes detecting the disruption by comparing respective flow rate data between the two or more received flow rate data groups.

16. An apparatus for delivery of nitric oxide and therapeutic gas to a patient, comprising:

a controller configured to control therapeutic gas flow to a patient in a first mode and to receive sensed flow rate data of breathing gas flow;

a memory configured to store received breathing gas flow rate data related to previous sensed historical flow data;

a detector configured to detect a disruption of received breathing gas flow rate data from the received breathing gas flow rate data; and

wherein the controller is further configured to retrieve historical flow rate data, and to control therapeutic gas flow rate in a temporary mode, instead of the first mode, based on the historical flow rate.

17. The apparatus of claim 16 , wherein the historical sensed flow rate data comprises one or more of a moving average breathing gas flow rate, a moving median breathing gas flow rate, and/or a breathing gas flow waveform.

18. The apparatus of claim 17 , wherein the historical flow rate data is stored over a period in the range from 10 seconds to 5 minutes.

19. The apparatus of claim 16 , wherein the controller is further configured return to the first mode when a discontinuance of the disruption is detected.

20. The apparatus of claim 16 , wherein:

the received sensed flow rate data comprises a first received flow rate data and a second received flow rate data from two or more sensors, and

detecting the disruption includes comparing flow rate data between the two or more received flow rate data.

Assignments (12)
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 043601, FRAME 0025 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0233 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2019
From: ACKER, JARON M.
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 050618/0347 →